Live Breaking News & Updates on Novel Antithrombotic

Stay updated with breaking news from Novel antithrombotic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ACTICOR BIOTECH: Presentation of Positive Results From the ACTIMIS Phase 1b/2a Study in Stroke at ESOC 2022

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT), a clinical-stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies,announces today the ....

Newton Biocapital , Mikael Mazighi , Venture Investment , European Stroke Organisation Conference , French National Institute Of Health , European Stroke Organisation , Regulatory News , Friday May , Professor Mikael Mazighi , Coordinating Investigator , Ceremony Large Clinical Trials , Novel Antithrombotic , Reduced Intracranial Hemorrhage , Mortality Rates , Standard Of Care Reperfusion Therapies , French National Institute , Medical Research , Mirae Asset Capital , Primer Capital , Acticor Biotech , Euronext Growth Paris , Stroke Journal ,